d-Streptamine, O-3-amino-3-deoxy--d-glucopyranosyl-(1® 6)-O-[2,6-diamino-2,3,6-trideoxy--d-ribo-hexopyranosyl-(1®4)]-2-deoxy-.
O-3-Amino-3-deoxy--d-glucopyranosyl-(1®4)- O-[2,6-diamino- 2,3,6-trideoxy--d-ribo-hexopyranosyl-(1®6)]-2-deoxy-l-streptamine [32986-56-4].
» Tobramycin has a potency of not less than 900 µg of C18H37N5O9 per mg, calculated on the anhydrous basis.
Packaging and storage Preserve in tight containers.
Labeling Where it is intended for use in preparing injectable or ophthalmic dosage forms, the label states that it is sterile or must be subjected to further processing during the preparation of injectable or ophthalmic dosage forms.
A: Prepare a solution of it in water containing 6 mg per mL. Apply 3 µL of this test solution, 3 µL of a Standard solution of USP Tobramycin RS containing 6 mg per mL, and 3 µL of a mixture of equal volumes of the two solutions to a suitable thin-layer chromatographic plate (see Chromatography 621) coated with a 0.25-mm layer of chromatographic silica gel mixture. Place the plate in a suitable chromatographic chamber, and develop the chromatogram in a solvent system consisting of a mixture of methanol, ammonium hydroxide, and chloroform (60:30:25) until the solvent front has moved about three-fourths of the length of the plate. Remove the plate from the chamber, allow the solvent to evaporate, and heat the plate at 110 for 15 minutes. Immediately locate the spots on the plate by spraying with a 1 in 100 solution of ninhydrin in a mixture of butyl alcohol and pyridine (100:1): tobramycin appears as a pink spot, and the spots obtained from the test solution and from the mixture of test solution and Standard solution, respectively, correspond in distance from the origin to that obtained from the Standard solution.
pH 791: between 9 and 11, in a solution (1 in 10).
Water, Method I 921: not more than 8.0%.
Residue on ignition 281: not more than 1.0%, the charred residue being moistened with 2 mL of nitric acid and 5 drops of sulfuric acid.
Heavy metals, Method II 231: 0.003%.
Diluted sodium hypochlorite solution Dilute 20 mL of sodium hypochlorite solution with water to obtain 100 mL of solution.
Starch-potassium iodide reagent Dissolve 1.1 g of potassium iodide in 60 mL of water, boil for 15 minutes, and slowly add a suspension of 1.5 g of soluble starch in 10 mL of water. Add 25 mL of water, and boil for 10 minutes. Allow to cool, dilute with water to 100 mL, and mix.
Procedure Transfer 50 mg of Tobramycin to a 10-mL volumetric flask, add 7 mL of water to dissolve it, and adjust with 1 N sulfuric acid to a pH of 5.5 ± 0.4. Dilute with water to volume, and mix to obtain the test solution. Prepare a standard solution by diluting the test solution quantitatively with water to obtain a solution containing 0.05 mg per mL. Separately apply 1 µL of these solutions to a thin-layer chromatographic plate (see Chromatography 621) coated with a 0.25-mm layer of chromatographic silica gel, and allow to dry. Develop the chromatogram in a saturated chromatographic chamber containing a mixture of sodium chloride solution (29.2 in 100), alcohol, and water (50:30:20) until the solvent front has moved about three-fourths of the length of the plate. Remove the plate from the chromatographic chamber, evaporate the solvent in a current of hot air, then heat it at 110 for 10 minutes. Lightly spray the hot plate with Diluted sodium hypochlorite solution. Dry the plate in a current of cold air until a sprayed area of the plate below the origin gives at most a faint blue color with a drop of Starch-potassium iodide reagent. Then spray the plate with Starch-potassium iodide reagent: bluish-purple spots are immediately visible. Other than the principal tobramycin spot, no spot observed in the chromatogram obtained from the test solution is more intense than the principal spot obtained from the standard solution (1.0%).
Other requirements Where the label states that Tobramycin is sterile, it meets the requirements for Sterility and Bacterial endotoxins under Tobramycin for Injection. Where the label states that Tobramycin must be subjected to further processing during the preparation of injectable dosage forms, it meets the requirements for Bacterial endotoxins under Tobramycin for Injection. Where it is intended for use in preparing ophthalmic dosage forms, it is exempt from the requirements for Bacterial endotoxins.
Mobile phase Dissolve 2.0 g of tris(hydroxymethyl)aminomethane in about 800 mL of water. To this solution add 20 mL of 1 N sulfuric acid, dilute with acetonitrile to obtain 2000 mL of solution, and mix. Allow to cool, and pass through a filter of 0.2-µm or finer porosity. Make adjustments if necessary (see System Suitability under Chromatography 621).
2 ,4-Dinitrofluorobenzene reagentPrepare a solution of 2,4-dinitrofluorobenzene in alcohol containing 10 mg per mL. This solution may be used for 5 days if refrigerated when not in use.
Tris (hydroxymethyl)aminomethane reagentPrepare a stock solution of tris(hydroxymethyl)aminomethane in water containing 15 mg per mL. This stock solution may be used for 1 month if refrigerated when not in use. Transfer 40 mL of this stock solution to a 200-mL volumetric flask, add dimethyl sulfoxide with mixing, dilute with dimethyl sulfoxide to volume, and mix. Use this reagent within 4 hours. [noteIf kept immersed in an ice-water bath below 10, the reagent may be used for up to 8 hours.]
Standard preparation Transfer about 55 mg of USP Tobramycin RS, accurately weighed, to a 50-mL volumetric flask, add 1 mL of 1 N sulfuric acid and enough water to dissolve it, dilute with water to volume, and mix. Transfer 10.0 mL of this solution to a second 50-mL volumetric flask, dilute with water to volume, and mix. This solution contains about 0.22 mg of USP Tobramycin RS per mL.
Assay preparation Transfer about 55 mg of Tobramycin, accurately weighed, to a 50-mL volumetric flask, add 1 mL of 1 N sulfuric acid and enough water to dissolve it, dilute with water to volume, and mix. Transfer 10.0 mL of this solution to a second 50-mL volumetric flask, dilute with water to volume, and mix.
Derivatization procedure [noteHeat all solutions at the same temperature and for the same duration of time as indicated. Move all flasks to and from the 60 constant temperature bath at the same time.] To separate 50-mL volumetric flasks transfer 4.0 mL of the Standard preparation, 4.0 mL of the Assay preparation, and 4.0 mL of water. To each flask add 10 mL of 2,4-Dinitrofluorobenzene reagent and 10 mL of Tris(hydroxymethyl)aminomethane reagent, shake, and insert the stopper. Place the flasks in a constant temperature bath at 60 ± 2, and heat for 50 ± 5 minutes. Remove the flasks from the bath, and allow to stand for 10 minutes. Add acetonitrile to about 2 mL below the 50-mL mark, allow to cool to room temperature, then dilute with acetonitrile to volume, and mix. The solutions thus obtained are the Derivatized standard preparation, the Derivatized assay preparation, and the Blank preparation, respectively.
Resolution solution Prepare a fresh solution of p-naphtholbenzein in acetonitrile containing about 0.24 mg per mL. Transfer 2 mL of this solution to a 10-mL volumetric flask, dilute with Derivatized standard preparation to volume, and use promptly.
Chromatographic system (see Chromatography 621)The liquid chromatograph is equipped with a 365-nm detector and a 3.9-mm × 30-cm column containing packing L1. The flow rate is about 1.2 mL per minute. Chromatograph the Blank preparation, and record the responses as directed for Procedure. Identify the solvent and reagent peaks. Chromatograph the Resolution solution, and record the responses as directed for Procedure: the relative retention times are about 0.6 for p-naphtholbenzein and 1.0 for tobramycin, and the resolution, R, between the two peaks is not less than 4.0. Chromatograph the Derivatized standard preparation, and record the responses as directed for Procedure: the relative standard deviation for replicate injections is not more than 2.0%.
Procedure Separately inject equal volumes (about 20 µL) of the Derivatized standard preparation and the Derivatized assay preparation into the chromatograph, record the chromatograms, and measure the area responses for the major peaks. Calculate the quantity, in µg, of C18H37N5O9 in each mg of the Tobramycin taken by the formula:
250(CE / W)(rU / rS)in which C is the concentration, in mg per mL, of USP Tobramycin RS in the Standard preparation; E is the tobramycin equivalent, in µg per mg, of USP Tobramycin RS; W is the weight, in mg, of the portion of Tobramycin taken; and rU and rS are the tobramycin peak area responses obtained from the Derivatized assay preparation and the Derivatized standard preparation, respectively.
Auxiliary Information Please check for your question in the FAQs before contacting USP.Chromatographic Column
USP32NF27 Page 3756
Chromatographic columns text is not derived from, and not part of, USP 32 or NF 27.